Churchill Downs vs DraftKings
CHDN and DKNG side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CHDN and DKNG compare
DraftKings is the larger company, worth 2.8 times as much as Churchill Downs ($18.6B against $6.6B).
DraftKings grew revenue faster over the last twelve months (15.0% versus 5.7% for Churchill Downs).
Churchill Downs keeps more of each dollar of sales as profit, with a net margin of 13.8% compared with −2.7% at DraftKings.
Churchill Downs pays a dividend yielding 0.46%; DraftKings does not pay one.
Churchill Downs scores higher on the StockData Score (13 against 9 for DraftKings), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CHDN | DKNG |
|---|---|---|
| Size and price | ||
| Market cap | $6.6B | $18.6B |
| Share price | $94.83 | $20.91 |
| Change, 1 year | −5.8% | −31.8% |
| Change, 5 years | −21.6% | −52.1% |
| Beta (5Y) | 0.91 | 2.15 |
| Employees | 9,000 | 5,500 |
| StockData Score | ||
| Total score | 13 (better) | 9 |
| Valuation score | 5 (better) | 0 |
| Growth score | 1 | 3 (better) |
| Performance score | 3 (better) | 1 |
| Health score | 1 | 5 (better) |
| Dividend score | 3 (better) | 0 |
| Valuation | ||
| P/E | 16.3× | – |
| P/S | 2.2× (better) | 3.0× |
| P/B | 4.9× (better) | 32.7× |
| EV/EBITDA | 11.7× (better) | 161× |
| P/FCF | – | 28.6× |
| FCF yield | – | 3.5% |
| Fair value | $144.14 | $3.30 |
| Margin of safety | 34.2% (better) | −533% |
| Growth | ||
| Revenue growth (TTM) | 5.7% | 15.0% (better) |
| Revenue growth, 5Y average | 22.7% | 58.0% (better) |
| Net income growth (TTM) | −4.1% | – |
| EPS growth (TTM) | −0.34% | – |
| Profitability | ||
| Gross margin | – | 40.5% |
| Operating margin | 24.1% (better) | −2.9% |
| Net margin | 13.8% (better) | −2.7% |
| FCF margin | – | 10.5% |
| Return on equity | 34.7% (better) | −21.1% |
| Return on invested capital | 8.8% | – |
| Financial health | ||
| Debt / equity | 3.56 (better) | 0.00 |
| Net debt / EBITDA | 4.80 | – |
| Interest coverage | 2.5× | – |
| Current ratio | 0.36 | 1.02 (better) |
| Altman Z-score | 1.47 | 2.21 (better) |
| Piotroski F-score | 6 | 8 (better) |
| Dividends and buybacks | ||
| Dividend yield | 0.46% | – |
| Payout ratio | 7.7% | – |
| Years of dividend growth | 15 | – |
| Dividend growth, 5Y average | 7.1% | – |
| Buyback yield | 1.3% | 2.6% (better) |
| Shareholder yield | 1.8% | 2.6% (better) |
| Ownership | ||
| Held by institutions | 85.9% | 45.9% |
| Held by insiders | 6.0% | 1.5% |
| Insider net buying, 12 months | – | −$17.5M |
| Short interest, % of float | 7.5% | 4.3% |
Go deeper
- CHDN stock overview
- CHDN income statement
- CHDN valuation and score
- DKNG stock overview
- DKNG income statement
- DKNG valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.